https://ctap-nmd.org/blog/ 2024-08-15T15:30:28+00:00 https://ctap-nmd.org/2019/09/26/ctap-analysis-nsaa/ 2020-02-11T18:12:33+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/business-wire.jpg https://ctap-nmd.org/2019/09/03/categorising-trajectories-individual-changes-nsaa-dmd-patients/ 2020-02-11T18:13:05+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/plos-one.jpg https://ctap-nmd.org/2019/09/01/2019-ean-abstract-a-phase-1b-2-study-rg6206/ 2020-02-11T18:17:55+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/ean-logo.jpg https://ctap-nmd.org/2019/06/12/2019-eu-ispor-nsaa-consistency-analysis/ 2020-02-11T18:18:36+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/ispor-logo.jpg https://ctap-nmd.org/2019/06/05/2019-eu-ispor-prognostic-model-loss-walking-ability-060519/ 2020-02-11T18:19:20+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/ispor-logo.jpg https://ctap-nmd.org/2019/05/31/2019-jscn-abstract-a-phase-1b-2-study-rg6206/ 2020-02-11T18:20:02+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/jscn-2019.jpg https://ctap-nmd.org/2019/04/13/2019-mda-abstract-nsaa-shift-analyses-nsuk/ 2020-02-11T18:20:34+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/mda-logo.jpg https://ctap-nmd.org/2019/04/13/2019-mda-abstract-collaborative-trajectory-analysis-project-ctap/ 2020-02-11T18:21:14+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/mda-logo.jpg https://ctap-nmd.org/2019/04/03/2019-ptc-wms-abstract-steroid-use-040219/ 2020-02-11T18:21:50+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2019/04/02/2019-wms-prognostic-model-loss-walking-ability-040219/ 2020-02-11T18:22:46+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2019/04/02/2019-wms-nsaa-consistency-analysis-040219/ 2020-02-11T18:23:35+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2019/04/02/2019-wms-abstract-fms-dexa-cchmc-040119/ 2020-02-11T18:24:22+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2019/04/02/2019-wms-mcid-4sc-nsaa-cchmc-040219/ 2020-02-11T18:25:18+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2019/03/25/2019-myology-abstract-longitudinal-analyses-4sc-velocity/ 2020-02-11T18:25:46+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/myology-2019.jpg https://ctap-nmd.org/2018/12/05/ctap-partner-james-signorovitch-wins-ispor-award/ 2020-02-11T18:26:53+00:00 https://ctap-nmd.org/wp-content/uploads/2018/12/Signorovitch_James.jpg https://ctap-nmd.org/2018/10/17/2018-ispor-eu-abstract-ambulatory-function-duchenne/ 2020-02-11T18:28:27+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/ispor-logo.jpg https://ctap-nmd.org/2018/10/17/moneyball-medicine-2018/ 2020-02-11T18:28:57+00:00 https://ctap-nmd.org/wp-content/uploads/2017/11/moneyball-medicine.jpg https://ctap-nmd.org/2018/10/17/longitudinal-analyses-of-4sc-velocity-in-leuven/ 2020-02-11T18:29:42+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/action-duchenne.jpg https://ctap-nmd.org/2018/10/03/wms-2018-abstract-consistency-6mwd/ 2020-02-11T18:30:09+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2018/10/03/wms-2018-abstract-minimal-change-nsaa/ 2020-02-11T18:30:53+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2018/10/02/was-2018-4sc-velocity-prognostic-model/ 2020-02-11T18:31:24+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2018/10/01/ctap-present-results-world-muscle-society-congress/ 2020-02-11T18:31:52+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/business-wire.jpg https://ctap-nmd.org/2018/08/31/2018-action-duchenne-consistency-year-change-6mwd/ 2020-02-11T18:32:45+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/action-duchenne.jpg https://ctap-nmd.org/2018/08/29/abstract-study-anti-myostatin-adnectin-rg6206/ 2020-02-11T18:33:13+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/action-duchenne.jpg https://ctap-nmd.org/2018/08/27/mcid-4sc-nsaa-cchmc/ 2020-02-11T18:33:37+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/action-duchenne.jpg https://ctap-nmd.org/2018/07/18/2018-icnmd-4sc-prognostic-model/ 2020-02-11T18:34:13+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/ICNMD2018.jpg https://ctap-nmd.org/2018/06/25/ctap-asa-biopharmaceutical-conference-2018/ 2020-02-11T18:34:49+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/asa.jpg https://ctap-nmd.org/2017/10/03/2017-wms-abstract-validation-score-changes-6mwd/ 2020-02-11T18:35:27+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2017/10/03/2017-wms-abstract-ctap/ 2020-02-11T18:36:01+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2017/10/03/2017-wms-abstract-consistency-nh-placebo/ 2020-02-11T18:36:34+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2017/10/03/2017-wms-clustering-trajectories-ambulatory-function/ 2020-02-11T18:37:09+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2017/09/29/summit-therapeutics-joins-ctap-to-support-the-development-of-potential-dmd-treatments/ 2020-02-11T18:37:38+00:00 https://ctap-nmd.org/wp-content/uploads/2018/02/Summit-logo.jpg https://ctap-nmd.org/2017/04/01/rd-partnerships/ 2020-02-11T18:38:21+00:00 https://ctap-nmd.org/wp-content/uploads/2017/04/pharma-voice-rd-partnerships-2.jpg https://ctap-nmd.org/2017/03/06/modern-solutions-to-recurring-roadblocks-in-clinical-testing/ 2020-02-11T18:38:52+00:00 https://ctap-nmd.org/wp-content/uploads/2017/03/modern-solutions-recurring-roadblocks-clinical-testing.jpg https://ctap-nmd.org/2017/02/07/marathon-pharmaceuticals-and-italfarmaco-join-ctap/ 2020-02-11T18:39:22+00:00 https://ctap-nmd.org/wp-content/uploads/2017/02/marathon-italfarmaco-join-ctap.jpg https://ctap-nmd.org/2017/02/03/2017-irdirc-translating-natural-history-to-clinical-trial-design/ 2020-02-11T18:40:31+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/IRDiRC.jpg https://ctap-nmd.org/2016/12/21/eli-lilly-joins-ctap/ 2020-02-11T18:41:06+00:00 https://ctap-nmd.org/wp-content/uploads/2016/12/eli-lilly-joins-ctap.jpg https://ctap-nmd.org/2016/10/31/ctap-announces-two-research-publications-categorizing-and-predicting-disease-progression-in-duchenne-muscular-dystrophy/ 2020-02-11T18:41:35+00:00 https://ctap-nmd.org/wp-content/uploads/2015/04/cTAP-contact-us-cells.jpg https://ctap-nmd.org/2016/10/25/launching-collaborative-trajectory-analysis-project-ctap/ 2020-02-11T18:42:07+00:00 https://ctap-nmd.org/wp-content/uploads/2016/10/ctap-launch.jpg https://ctap-nmd.org/2016/12/01/nontraditional-approaches-to-big-data-analyses-a-case-study-in-rare-disease/ 2020-02-11T18:43:07+00:00 https://ctap-nmd.org/wp-content/uploads/2016/12/nontraditional-approaches-data-analyses.jpg https://ctap-nmd.org/2016/10/13/individualized-prediction-of-changes-in-6-minute-walk-distance-for-patients-with-duchenne-muscular-dystrophy/ 2020-02-11T18:43:48+00:00 https://ctap-nmd.org/wp-content/uploads/2016/10/individualized-prediction-six-minute-walking-duchenne.jpg https://ctap-nmd.org/2019/08/02/ctap-2019-nord-summit/ 2020-03-18T15:42:00+00:00 https://ctap-nmd.org/wp-content/uploads/2019/08/nord.png https://ctap-nmd.org/2018/05/19/ctap-2018-ispor-conference/ 2020-03-19T15:15:11+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/ispor-logo.jpg https://ctap-nmd.org/2018/11/09/ctap-2018-action-duchenne-conference/ 2020-03-19T15:15:52+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/action-duchenne.jpg https://ctap-nmd.org/2015/06/19/ctap-2015-ppmd-conference/ 2020-03-19T15:20:28+00:00 https://ctap-nmd.org/wp-content/uploads/2020/01/ppmd.png https://ctap-nmd.org/2015/12/06/ctap-2015-treat-nmd-conference/ 2020-03-19T15:25:56+00:00 https://ctap-nmd.org/wp-content/uploads/2020/03/treat-nmd.png https://ctap-nmd.org/2015/11/11/ctap-2015-world-congress-orphan-disease-conference/ 2020-03-19T15:32:11+00:00 https://ctap-nmd.org/wp-content/uploads/2020/03/world-orphan-drug.png https://ctap-nmd.org/2019/11/06/branca-their-lives-their-hands-november-2019/ 2020-04-06T14:04:10+00:00 https://ctap-nmd.org/wp-content/uploads/2020/04/their-lives-their-hands-branca-nature-biotechnology.jpg https://ctap-nmd.org/2017/02/08/ctap-2017-irdirc-conference/ 2020-04-16T14:30:02+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/IRDiRC.jpg https://ctap-nmd.org/2018/09/12/ctap-2018-asa-biopharmaceutical-section-regulatory-industry-workshop/ 2020-04-17T14:28:18+00:00 https://ctap-nmd.org/wp-content/uploads/2020/04/asa.png https://ctap-nmd.org/2020/06/23/prognostic-model-1-year-change-4sc/ 2020-08-24T21:18:12+00:00 https://ctap-nmd.org/wp-content/uploads/2019/09/plos-one.jpg https://ctap-nmd.org/2020/09/08/suitability-external-controls-drug-evaluation-duchenne/ 2020-09-09T12:13:16+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/neurology-journal.png https://ctap-nmd.org/2020/01/10/deflazacort-versus-prednisone-duchenne-muscular-dystrophy/ 2020-09-28T14:19:35+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/muscle-nerve.png https://ctap-nmd.org/2020/01/10/outcomes-prednisone-deflazacort-duchenne-patients/ 2020-09-28T14:34:30+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/jecr-logo.png https://ctap-nmd.org/2020/09/08/study-finds-real-world-data-comparable-to-placebo-data-duchenne/ 2020-09-28T14:41:59+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/neurology-journal.png https://ctap-nmd.org/2020/09/28/2020-wms-abstract-prognostic-factors-loss-ability-rise-from-supine-dmd/ 2020-10-05T19:15:11+00:00 https://ctap-nmd.org/wp-content/uploads/2018/10/wms2018.jpg https://ctap-nmd.org/2021/01/15/ctap-2020-react-congress-irdirc-conference/ 2021-03-26T20:56:57+00:00 https://ctap-nmd.org/wp-content/uploads/2020/01/redact-logo.png https://ctap-nmd.org/2021/11/16/problem-clinical-trials-duchenne-gen/ 2021-11-30T00:09:59+00:00 https://ctap-nmd.org/wp-content/uploads/2021/11/gen-eng-biotech-news-logo.png https://ctap-nmd.org/2021/09/24/2021-wms-poster-genotype-poster/ 2021-11-30T00:16:13+00:00 https://ctap-nmd.org/wp-content/uploads/2021/11/wms-2021.png https://ctap-nmd.org/2022/04/06/predicting-trajectories-ambulatory-function-dmd-poster-aan-2022/ 2022-05-02T12:10:55+00:00 https://ctap-nmd.org/wp-content/uploads/2022/05/aan-2022.png https://ctap-nmd.org/2022/04/06/ambulatory-assessment-enhancing-research-dmd-aan-2022/ 2022-05-02T12:13:32+00:00 https://ctap-nmd.org/wp-content/uploads/2022/05/aan-2022.png https://ctap-nmd.org/2022/04/01/real-world-and-natural-history-data-for-drug-evaluation-dmd/ 2023-02-08T18:16:19+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/02/08/beyond-placebo-controls-rare-disease-trials-ctap-evidence-patient-centric-alternatives/ 2023-12-27T17:38:01+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/neurology-journal.png https://ctap-nmd.org/2023/02/01/dmd-genotypes-and-motor-function-in-duchenne-muscular-dystrophy/ 2023-12-27T17:48:49+00:00 https://ctap-nmd.org/wp-content/uploads/2020/09/neurology-journal.png https://ctap-nmd.org/2016/05/24/categorizing-natural-history-trajectories-of-ambulatory-function-measured-by-the-6-minute-walk-distance-in-patients-with-duchenne-muscular-dystrophy/ 2023-12-27T17:51:03+00:00 https://ctap-nmd.org/wp-content/uploads/2016/05/categorizing-natural-history-trajectories.jpg https://ctap-nmd.org/2023/12/27/ctap-at-the-2020-ppmd-clinical-care-conference-virtual-congress/ 2023-12-27T17:52:03+00:00 https://ctap-nmd.org/wp-content/uploads/2023/12/PPMD-Logo.png https://ctap-nmd.org/2023/12/27/ctap-at-the-2021-ppmd-duchenne-drug-development-roundtable/ 2023-12-27T17:52:25+00:00 https://ctap-nmd.org/wp-content/uploads/2023/12/PPMD-Logo.png https://ctap-nmd.org/2023/12/27/accelerating-clinical-development-of-new-therapeutics-with-patient-data-evidence-from-the-collaborative-trajectory-analysis-program-ctap-in-dmd/ 2023-12-27T17:52:56+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/validation-of-a-composite-prognostic-score-for-time-to-loss-of-ambulation-in-duchenne-muscular-dystrophy/ 2023-12-27T17:53:33+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/genotype-unmatched-controls-are-feasible-for-drug-development-in-duchenne-muscular-dystrophy-dmd/ 2023-12-27T17:53:55+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/development-and-evaluation-of-a-time-to-event-endpoint-for-clinical-trials-in-duchenne-muscular-dystrophy-dmd/ 2023-12-27T17:54:21+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/consistency-of-changes-in-predicted-forced-vital-capacity-between-real-world-data-and-trial-placebo-arms-in-ambulatory-duchenne-muscular-dystrophy/ 2023-12-27T17:54:39+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/a-concisely-recorded-ambulatory-assessment-for-enhancing-real-world-outcomes-research-in-duchenne-muscular-dystrophy-development-and-validation/ 2023-12-27T17:55:00+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/associations-between-dystrophin-genotype-and-ambulatory-outcomes-in-dmd-implications-for-trials-of-genotype-targeted-therapies/ 2023-12-27T17:57:04+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/functional-trajectories-of-upper-limb-and-pulmonary-function-before-and-after-loss-of-ambulation-in-duchenne-muscular-dystrophy/ 2023-12-27T17:58:35+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/prognostic-factors-for-pulmonary-milestones-in-duchenne-muscular-dystrophy/ 2023-12-27T17:59:46+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2023/12/27/minimal-detectable-changes-in-functional-measures-in-duchenne-muscular-dystrophy-a-study-of-multiple-centers-networks-and-trial-arms/ 2023-12-27T18:01:05+00:00 https://ctap-nmd.org/wp-content/uploads/2023/02/neuromuscular-disorders-logo.png https://ctap-nmd.org/2024/08/15/ctap-study-indicates-dmd-clinical-trial-enrollment-criteria/ 2024-08-15T15:23:43+00:00 https://ctap-nmd.org/wp-content/uploads/2024/08/PLOS-ONE-logo.png https://ctap-nmd.org/2024/08/15/new-study-may-help-more-dmd-patients-be-included-in-clinical-trials/ 2024-08-15T15:24:08+00:00 https://ctap-nmd.org/wp-content/uploads/2024/08/md-news-today.png https://ctap-nmd.org/2024/08/15/functional-trajectories-before-and-after-loss-of-ambulation-in-duchenne-muscular-dystrophy/ 2024-08-15T15:29:09+00:00 https://ctap-nmd.org/wp-content/uploads/2024/08/PLOS-ONE-logo.png https://ctap-nmd.org/2024/08/15/meaningful-changes-in-motor-function-in-duchenne-muscular-dystrophy/ 2024-08-15T15:30:28+00:00 https://ctap-nmd.org/wp-content/uploads/2024/08/PLOS-ONE-logo.png